These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2213827

  • 1. Penta- and hexadienoic acid derivatives: a novel series of 5-lipoxygenase inhibitors.
    Malleron JL, Roussel G, Gueremy G, Ponsinet G, Robin JL, Terlain B, Tissieres JM.
    J Med Chem; 1990 Oct; 33(10):2744-9. PubMed ID: 2213827
    [Abstract] [Full Text] [Related]

  • 2. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.
    Carlson RP, O'Neill-Davis L, Chang J, Lewis AJ.
    Agents Actions; 1985 Dec; 17(2):197-204. PubMed ID: 3938181
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
    Shrivastava SK, Srivastava P, Bandresh R, Tripathi PN, Tripathi A.
    Bioorg Med Chem; 2017 Aug 15; 25(16):4424-4432. PubMed ID: 28669741
    [Abstract] [Full Text] [Related]

  • 4. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC, Ritchie DM, Ferro MP, Kirchner T, Wachter MP, Anderson DW, Rosenthale ME, Capetola RJ.
    J Pharmacol Exp Ther; 1994 Dec 15; 271(3):1399-408. PubMed ID: 7996452
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In-vitro versus in-vivo activities of new 5-lipoxygenase inhibitors with antiinflammatory activity.
    Montandon JB, Zijlstra FJ, Wilson JH, Grandjean EM, Cicurel L.
    Int J Tissue React; 1989 Dec 15; 11(3):107-12. PubMed ID: 2515163
    [Abstract] [Full Text] [Related]

  • 9. Aromatic sulfide inhibitors of histone deacetylase based on arylsulfinyl-2,4-hexadienoic acid hydroxyamides.
    Marson CM, Savy P, Rioja AS, Mahadevan T, Mikol C, Veerupillai A, Nsubuga E, Chahwan A, Joel SP.
    J Med Chem; 2006 Jan 26; 49(2):800-5. PubMed ID: 16420064
    [Abstract] [Full Text] [Related]

  • 10. Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenase.
    Malamas MS, Carlson RP, Grimes D, Howell R, Glaser K, Gunawan I, Nelson JA, Kanzelberger M, Shah U, Hartman DA.
    J Med Chem; 1996 Jan 05; 39(1):237-45. PubMed ID: 8568813
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors.
    Satoh Y, Stanton JL, Hutchison AJ, Libby AH, Kowalski TJ, Lee WH, White DH, Kimble EF.
    J Med Chem; 1993 Nov 12; 36(23):3580-94. PubMed ID: 8246226
    [Abstract] [Full Text] [Related]

  • 13. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
    Horizoe T, Nagakura N, Chiba K, Shirota H, Shinoda M, Kobayashi N, Numata H, Okamoto Y, Kobayashi S.
    Inflamm Res; 1998 Oct 12; 47(10):375-83. PubMed ID: 9831321
    [Abstract] [Full Text] [Related]

  • 14. Effect of anti-inflammatory compounds on edema formation and myeloperoxidase activity in the arachidonic acid-induced ear model in the mouse.
    Kotyuk B, Raychaudhuri A, DiPasquale G.
    Agents Actions; 1993 Oct 12; 39 Spec No():C46-8. PubMed ID: 8273582
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-inflammatory effect of YPE-01, a novel diarylheptanoid derivative, on dermal inflammation in mice.
    Yamazaki R, Aiyama R, Matsuzaki T, Hashimoto S, Yokokura T.
    Inflamm Res; 1998 Apr 12; 47(4):182-6. PubMed ID: 9628261
    [Abstract] [Full Text] [Related]

  • 17. Thiopyranol[2,3,4-c,d]indoles as inhibitors of 5-lipoxygenase, 5-lipoxygenase-activating protein, and leukotriene C4 synthase.
    Hutchinson JH, Charleson S, Evans JF, Falgueyret JP, Hoogsteen K, Jones TR, Kargman S, Macdonald D, McFarlane CS, Nicholson DW.
    J Med Chem; 1995 Oct 27; 38(22):4538-47. PubMed ID: 7473582
    [Abstract] [Full Text] [Related]

  • 18. 3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors.
    Sogawa S, Nihro Y, Ueda H, Izumi A, Miki T, Matsumoto H, Satoh T.
    J Med Chem; 1993 Nov 26; 36(24):3904-9. PubMed ID: 8254620
    [Abstract] [Full Text] [Related]

  • 19. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
    McMillan RM, Spruce KE, Crawley GC, Walker ER, Foster SJ.
    Br J Pharmacol; 1992 Dec 26; 107(4):1042-7. PubMed ID: 1334748
    [Abstract] [Full Text] [Related]

  • 20. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
    Chowdhury MA, Abdellatif KR, Dong Y, Das D, Suresh MR, Knaus EE.
    Bioorg Med Chem Lett; 2008 Dec 01; 18(23):6138-41. PubMed ID: 18945614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.